Concepedia

Zsolt Cselényi

ZC

40

Publications

2.3K

Citations

28

H-Index

2002

Active since

Affiliations

Karolinska Institutet(Current)

AstraZeneca (Sweden)

Karolinska University Hospital

Stockholm County Council

AstraZeneca (United States)

Zsolt Cselényi is an author at Karolinska Institutet specializing in medicine, neuroscience, and neuropharmacology.

ORCID

Top concepts

Publications per year

2002–2022

40

Publications

40

Clinical Validation of <sup>18</sup>F-AZD4694, an Amyloid-β–Specific PET Radioligand

Zsolt Cselényi, Maria Eriksdotter, Anton Forsberg et al. · Journal of Nuclear Medicine · 2012 · 221 citations · Full text

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson’s disease

Aurelija Jučaitė, Per Svenningsson, Juha O. Rinne et al. · Brain · 2015 · 219 citations · Full text

Head-to-Head Comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-AZD4694 (NAV4694) for β-Amyloid Imaging in Aging and Dementia

Christopher C. Rowe, Svetlana Pejoska, Rachel S. Mulligan et al. · Journal of Nuclear Medicine · 2013 · 180 citations · Full text

Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects

Aurelija Jučaitė, Zsolt Cselényi, Annie Arvidsson et al. · EJNMMI Research · 2012 · 99 citations · Full text

Nigrostriatal dopamine transporter availability in early Parkinson's disease

Patrik Fazio, Per Svenningsson, Zsolt Cselényi et al. · Movement Disorders · 2018 · 95 citations

Rows per page

1–5 of 40